Interestingly, mutations in PDGFRB also cause autosomal-dominant infantile myofibromatosis, Penttinen syndrome, and a novel overgrowth syndrome characterized by somatic overgrowth, distinctive facial features, hyper-elastic and fragile skin, white matter lesions, and neurologic deterioration37–40. Here, PDGFRB is linked to overgrowth syndrome.